• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在干热和湿热条件下美拉德反应的葡萄糖-氨基酸模型中晚期糖基化终产物的形成。

Formation of advanced glycation end products in glucose-amino acid models of Maillard reaction under dry- and wet-heating conditions.

作者信息

Zhang Chen-Yang, Guo Yu-Rong, Hou Tian-Yu, Ning Qian-Ru, Han Wan-Yu, Zhao Xing-Yun, Cui Feng, Li He

机构信息

School of Chemistry and Chemical Engineering, North University of China, Taiyuan, China.

Modern Research Center for Traditional Chinese Medicine, Key Laboratory of Chemical Biology and Molecular Engineering of Ministry of Education, Shanxi University, Taiyuan, China.

出版信息

J Sci Food Agric. 2025 Mar 15;105(4):2342-2351. doi: 10.1002/jsfa.14004. Epub 2024 Nov 5.

DOI:10.1002/jsfa.14004
PMID:39501682
Abstract

BACKGROUND

Advanced glycation end products (AGEs) are compounds formed by non-enzymatic processes in the Maillard reaction and can cause various chronic diseases. This study explores the AGE formation process in a glucose-amino acid system under both wet- and dry-heating conditions, and analyzes the effect of cysteine in AGE formation.

RESULTS

Under wet-heating conditions, N-carboxymethyllysine (CML) and N-carboxyethyllysine (CEL) concentrations rose for the initial 90 min and subsequently declined after 120 min; after 90 min of heating, the maximum yields in the absence of cysteine were 1151.04 ± 14.01 and 3386.90 ± 26.55 ng mL, respectively. The concentration of pyrraline (Pyr) increased after 30 min and then decreased after 60 min with a maximum yield of 777.68 ± 23.36 ng mL. However, in dry-heating models, the AGE concentrations consistently increased with increasing heating time; the maximum yields for CML, CEL and Pyr were 468.66 ± 10.96, 1993.57 ± 14.81 and 1085.74 ± 58.06 ng mL, respectively. The addition of cysteine showed an inhibitory effect on AGE formation, especially for Pyr in the dry-heating model, with inhibition rates ranging from 17.14% to 95.60%.

CONCLUSION

Although wet-heating models produced more CML and CEL, they produced less Pyr than dry-heating models. The AGE formation in wet-heating models positively correlated with the reaction rate; however, the dry-heating reaction demonstrated a more complex relationship between reaction rate and reaction protocol. Moreover, cysteine exhibited a significant inhibitory effect on AGE production, and the degree of inhibition was proportional to the cysteine concentration. This study provides important insights into the mechanisms for AGE formation under various heating conditions, such as those representing baking (dry-heating) and steaming conditions (wet-heating). © 2024 Society of Chemical Industry.

摘要

背景

晚期糖基化终产物(AGEs)是美拉德反应中非酶促过程形成的化合物,可引发多种慢性疾病。本研究探究了葡萄糖-氨基酸体系在湿热和干热条件下AGE的形成过程,并分析了半胱氨酸对AGE形成的影响。

结果

在湿热条件下,N-羧甲基赖氨酸(CML)和N-羧乙基赖氨酸(CEL)浓度在最初90分钟上升,120分钟后下降;加热90分钟后,无半胱氨酸时的最大产量分别为1151.04±14.01和3386.90±26.55纳克/毫升。吡咯赖氨酸(Pyr)浓度在30分钟后升高,60分钟后下降,最大产量为777.68±23.36纳克/毫升。然而,在干热模型中,AGE浓度随加热时间延长持续增加;CML、CEL和Pyr的最大产量分别为468.66±10.96、1993.57±14.81和1085.74±58.06纳克/毫升。添加半胱氨酸对AGE形成有抑制作用,尤其是在干热模型中对Pyr的抑制作用,抑制率在17.14%至95.60%之间。

结论

尽管湿热模型产生的CML和CEL更多,但产生的Pyr比干热模型少。湿热模型中AGE的形成与反应速率呈正相关;然而,干热反应表明反应速率与反应方案之间的关系更为复杂。此外,半胱氨酸对AGE的产生有显著抑制作用,抑制程度与半胱氨酸浓度成正比。本研究为各种加热条件下AGE形成的机制提供了重要见解,例如代表烘焙(干热)和蒸煮条件(湿热)的情况。©2024化学工业协会。

相似文献

1
Formation of advanced glycation end products in glucose-amino acid models of Maillard reaction under dry- and wet-heating conditions.在干热和湿热条件下美拉德反应的葡萄糖-氨基酸模型中晚期糖基化终产物的形成。
J Sci Food Agric. 2025 Mar 15;105(4):2342-2351. doi: 10.1002/jsfa.14004. Epub 2024 Nov 5.
2
Dietary glycation compounds - implications for human health.饮食糖化化合物 - 对人类健康的影响。
Crit Rev Toxicol. 2024 Sep;54(8):485-617. doi: 10.1080/10408444.2024.2362985. Epub 2024 Aug 16.
3
Influence of hydroxyl substitution on the inhibition of flavonoids in advanced glycation end-products formation in glucose-lysine-arginine Maillard reaction models.羟基取代对黄酮类化合物在葡萄糖-赖氨酸-精氨酸美拉德反应模型中抑制晚期糖基化终产物形成的影响。
Food Res Int. 2025 Apr;207:116068. doi: 10.1016/j.foodres.2025.116068. Epub 2025 Feb 27.
4
Multi-response kinetic study of Maillard reaction hazards in the glucose-lysine model system.葡萄糖-赖氨酸模型体系中美拉德反应危害的多响应动力学研究
J Sci Food Agric. 2025 Jan 30;105(2):1207-1215. doi: 10.1002/jsfa.13911. Epub 2024 Sep 19.
5
N -carboxymethyllysine and N -carboxyethyllysine kinetics and water loss analysis during chicken braising.鸡红烧过程中 N -羧甲基赖氨酸和 N -羧乙基赖氨酸的动力学和水分损失分析。
J Sci Food Agric. 2021 Jan 30;101(2):388-397. doi: 10.1002/jsfa.10528. Epub 2020 Oct 1.
6
Kinetic Study on Peptide-Bound Pyrraline Formation and Elimination in the Maillard Reaction Using Single- and Multiple-Response Models.使用单响应和多响应模型对美拉德反应中肽结合的吡咯啉形成与消除的动力学研究
J Food Sci. 2016 Oct;81(10):C2405-C2424. doi: 10.1111/1750-3841.13428. Epub 2016 Sep 14.
7
Formation mechanism of AGEs in Maillard reaction model systems containing ascorbic acid.含抗坏血酸的美拉德反应模型体系中 AGEs 的形成机制。
Food Chem. 2022 Jun 1;378:132108. doi: 10.1016/j.foodchem.2022.132108. Epub 2022 Jan 10.
8
Nutrient and Maillard reaction product concentrations of commercially available pet foods and treats.市售宠物食品和零食的营养成分和美拉德反应产物浓度。
J Anim Sci. 2022 Nov 1;100(11). doi: 10.1093/jas/skac305.
9
Formation and kinetic analysis of AGEs in Pacific white shrimp during frying.油炸过程中太平洋白对虾中 AGEs 的形成及动力学分析。
Food Chem. 2024 Dec 1;460(Pt 2):140408. doi: 10.1016/j.foodchem.2024.140408. Epub 2024 Jul 25.
10
Formation of advanced glycation endproducts in ground beef under pasteurisation conditions.在巴氏杀菌条件下碎牛肉中晚期糖基化终产物的形成。
Food Chem. 2015 Apr 1;172:802-7. doi: 10.1016/j.foodchem.2014.09.129. Epub 2014 Sep 28.

引用本文的文献

1
Maillard Reaction-Derived Carbon Nanodots: Food-Origin Nanomaterials with Emerging Functional and Biomedical Potential.美拉德反应衍生的碳纳米点:具有新兴功能和生物医学潜力的食品源纳米材料。
Pharmaceutics. 2025 Aug 13;17(8):1050. doi: 10.3390/pharmaceutics17081050.